Scott+Scott Attorneys at Law LLP again warns investors of the continuation of investigation by Transmedics Group, Inc. (™ dx) by investing.com
New York, New York – (Newsfile Corp. – January 25, 2025) – Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a Consumer and Consumer Rights Firm, is investigating whether Transmedics Group (NASDAQ :), Inc. (“Transmedics Group” or “Company”) (NASDAQ: ™ DX) or certain officials and directors issued deceitful and false statements and/or did not disclose information material to investors, violating the Federal Securities Laws.
Click here to receive additional information about this potential group lawsuit
The Transmedics Group manages the organ transplant ecosystem within which it offers patented technology for organ preservation and mobilization, services supporting transplant centers and medical teams and logistical branch that facilitates the entire chain.
October 28, 2024. The company published its financial results for the 3rd quarter 2024. During the connected earnings of earnings, the company revealed that its revenues were far from estimating and that the revenues were falling consecutively. After this news, the price of the company’s stock fell by $ 39.24, or more than 30%, October 29, 2024, trading with a great volume of trading.
Then, after the working hours of the market on December 2, 2024, the Transmedics Group issued a statement for the public, which, among other things, revealed additional information about the expected growth of society. In particular, the company has reduced its revenue guidelines for FG24 with between $ 425 and $ 445 million to $ 428 million and $ 432 million. After this news, the company’s shares fell for $ 13.70, or more than $ 16%, and closed at $ 71.44 on a section on December 3, 2024, with an unusually large volume.
Are you a potential member of the class that fulfills the rights for recovery? Click here
If you have purchased or otherwise owning a Transmedics Group’s securities and have suffered loss, realized or unrealized, and want to talk about this investigation, Contact lawyer Nicholas Bruno on (888) 398-9312 or on nbruno@scott-scott.com.
Click here to find out if you can reimburse your losses
About us
Scott+Scott is an international law firm known for its expertise in the representation of corporate clients, institutional investors, companies and individuals damaged by behavior against market competition or other forms of illegal treatment, including violations of securities and shareholders law. With more than 100 lawyers in eight offices in the United States, as well as three offices in Europe, our representation resulted in significant monetary settlements on behalf of our clients, along with other forms of assistance. Lawdragon, WWL: Commercial Litigation 2024 and Legal 500 in Antitruist Civil Litigation have recognized our very experienced lawyers as among the best financial lawyers in 2024, and received the best ranking of Chambers 2024. In addition, we have repeatedly received recognition by the US Institute for Protection of market competition for successful litigation regarding high role against market competition in the United States. To find out more about Scott+Scott, our lawyers or solving complex cases, visit www.scott-scott.com.
This can be considered as an advertising of a lawyer.
For an overview of the original version of this press release, visit https://www.newsfilecorp.com/release/237019
